rotation.to
Following this device: dark.
Free account
rotation.to
Sign in / Request free access
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Oreola Donini

Cso

Company insider

Files Form 4 as: Cso, Soligenix.

Every Form 4 they filed

In numbers

Trades disclosed
18
Buys
0
Sells
0
Bought
$0
Sold
$0
Companies
1
Companies where not an officer
0
First trade
31 Dec 2015
Last trade
12 Oct 2026
Last filed
13 Oct 2026

Companies traded

Where they are an officer
SNGX SoligenixOfficer · Biotechnology · last 12 Oct 20260 buys · 0 sells

Activity over time

Not enough dated trades to draw.

Every trade

TradedCompanyWhatAmount
12 Oct 2026filed 13 Oct 2026SNGX Soligenixoption or derivative · BiotechnologySEC FORM 4 Code D—83 at $0.00filing
12 Oct 2026filed 13 Oct 2026SNGX Soligenixoption or derivative · BiotechnologySEC FORM 4 Code D—145 at $0.00filing
12 Oct 2026filed 13 Oct 2026SNGX Soligenixoption or derivative · BiotechnologySEC FORM 4 Code D—166 at $0.00filing
12 Oct 2026filed 13 Oct 2026SNGX Soligenixoption or derivative · BiotechnologySEC FORM 4 Code D—250 at $0.00filing
12 Oct 2026filed 13 Oct 2026SNGX Soligenixoption or derivative · BiotechnologySEC FORM 4 Code D—291 at $0.00filing
12 Oct 2026filed 13 Oct 2026SNGX Soligenixoption or derivative · BiotechnologySEC FORM 4 Code D—291 at $0.00filing
12 Oct 2026filed 13 Oct 2026SNGX Soligenixoption or derivative · BiotechnologySEC FORM 4 Code D—333 at $0.00filing
11 Dec 2025filed 12 Dec 2025SNGX Soligenixoption or derivative · BiotechnologySEC FORM 4 Code A—100,000 at $0.00filing
12 Dec 2024filed 13 Dec 2024SNGX Soligenixoption or derivative · BiotechnologySEC FORM 4 Code A—20,000 at $0.00filing
8 Dec 2023filed 8 Dec 2023SNGX Soligenixoption or derivative · BiotechnologySEC FORM 4 Code A—90,000 at $0.00filing
8 Dec 2022filed 9 Dec 2022SNGX Soligenixoption or derivative · BiotechnologySEC FORM 4 Code A—80,000 at $0.00filing
9 Dec 2021filed 10 Dec 2021SNGX Soligenixoption or derivative · BiotechnologySEC FORM 4 Code A—70,000 at $0.00filing
10 Dec 2020filed 11 Dec 2020SNGX Soligenixoption or derivative · BiotechnologySEC FORM 4 Code A—70,000 at $0.00filing
12 Dec 2019filed 13 Dec 2019SNGX Soligenixoption or derivative · BiotechnologySEC FORM 4 Code A—60,000 at $0.00filing
13 Dec 2018filed 14 Dec 2018SNGX Soligenixoption or derivative · BiotechnologySEC FORM 4 Code A—40,000 at $0.00filing
7 Dec 2017filed 11 Dec 2017SNGX Soligenixoption or derivative · BiotechnologySEC FORM 4 Code A—35,000 at $0.00filing
31 Mar 2017filed 4 Apr 2017SNGX Soligenixoption or derivative · BiotechnologySEC FORM 4 Code A—20,000 at $0.00filing
31 Dec 2015filed 4 Jan 2016SNGX Soligenixoption or derivative · BiotechnologySEC FORM 4 Code A—70,000 at $0.00filing

News

No headline names them, or the companies they trade most, lately.

Sectors

No trade we could place in a sector.

Related people

Jerome B. ZeldisDirector · Director at Soligenix, filing Form 4 there in the last year
Anthony Gregg LapointeDirector · Director at Soligenix, filing Form 4 there in the last year
Robert J. RubinDirector · Director at Soligenix, filing Form 4 there in the last year
Christopher J. SchaberChairman, CEO and President · Chairman, CEO and President at Soligenix, filing Form 4 there in the last year
Jonathan L. GuarinoCFO · CFO at Soligenix, filing Form 4 there in the last year